Avidity Biosciences Inc (RNA)
42.56
-1.09
(-2.50%)
USD |
NASDAQ |
Nov 21, 16:00
42.55
-0.01
(-0.02%)
After-Hours: 20:00
Avidity Biosciences Profit Margin (Quarterly): -3.44K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.44K% |
| June 30, 2024 | -3.46K% |
| March 31, 2024 | -1.94K% |
| December 31, 2023 | -2.76K% |
| September 30, 2023 | -1.86K% |
| June 30, 2023 | -2.03K% |
| March 31, 2023 | -2.35K% |
| December 31, 2022 | -1.82K% |
| September 30, 2022 | -1.76K% |
| June 30, 2022 | -2.10K% |
| March 31, 2022 | -1.91K% |
| Date | Value |
|---|---|
| December 31, 2021 | -2.08K% |
| September 30, 2021 | -1.35K% |
| June 30, 2021 | -1.01K% |
| March 31, 2021 | -881.8% |
| December 31, 2020 | -759.8% |
| September 30, 2020 | -655.2% |
| June 30, 2020 | -685.0% |
| March 31, 2020 | -448.1% |
| December 31, 2019 | -719.8% |
| September 30, 2019 | -1.03K% |
| June 30, 2019 | -2.28K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.46K%
Minimum
Jun 2024
-448.1%
Maximum
Mar 2020
-1.70K%
Average
-1.84K%
Median
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 7.19% |
| Vertex Pharmaceuticals Inc | 37.71% |
| Natera Inc | -7.18% |
| Entrada Therapeutics Inc | -71.70% |
| Alnylam Pharmaceuticals Inc | -22.27% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -30.66% |
| Return on Assets | -27.28% |
| Return on Invested Capital | -30.66% |
| Operating Margin (Quarterly) | -4.20K% |
| Return on Net Operating Assets | -784.3% |